Qualio is a unified quality and compliance platform that helps growing life sciences companies scale faster while staying continuously audit- and inspection-ready. Medical device, digital health, biotech, and pharma teams use Qualio to replace manual processes and disconnected tools with a single source of truth for quality, regulatory readiness, and risk.
With a modern eQMS at the foundation and Compliance Intelligence layered on top, Qualio moves teams beyond point-in-time audits. Automated gap analysis, cross-standard evidence mapping, and real-time readiness dashboards provide confidence that the organization is prepared today—not just when auditors arrive.
Qualio centralizes document control, training, CAPA, change management, supplier quality, and design controls, linking them directly to regulatory requirements and product lifecycle data. Executive-ready views show compliance health by standard, region, and product, turning regulatory readiness into a measurable business capability instead of a black box.
Compliance Intelligence continuously monitors for risk, highlights gaps early, and prioritizes remediation so teams focus effort where it matters most. Pre-validated regulatory frameworks are maintained as requirements evolve, reducing reliance on consultants and avoiding duplicate work as companies expand.
The result is faster market entry, lower compliance cost, reduced risk of findings or recalls, and confident, risk-managed growth.
Learn more
D&B Hoovers accelerates the journey from prospecting to establishing profitable client relationships more efficiently. By identifying crucial prospects and potential areas for growth, it serves as a powerful sales acceleration tool that leverages data and analytics. B2B sales professionals can engage with clients swiftly, enhancing their business development efforts. With access to comprehensive intelligence across more than 120 million business records, users gain valuable insights that empower their marketing and sales strategies. The platform features an intuitive interface alongside automated workflows, including alerts, triggers, and smart lists, which simplify the user experience. Furthermore, D&B Hoovers merges Dun & Bradstreet's extensive commercial database with advanced analytics to deliver a robust sales intelligence solution. This service also offers versatile search and list-building capabilities, real-time alerts, in-depth company profiles, and insightful research reports to support informed decision-making in the sales process. Overall, D&B Hoovers positions your organization for success by enhancing the efficiency and effectiveness of your sales efforts.
Learn more
BenevolentAI
BenevolentAI is a groundbreaking platform that harnesses the power of artificial intelligence and advanced scientific methodologies to improve the drug discovery process, particularly for challenging diseases, by swiftly analyzing and interpreting vast amounts of biomedical data to generate practical insights more quickly than traditional methods. Through its distinctive Benevolent Platform, the company adeptly combines both structured and unstructured biomedical data—including literature, genomic information, clinical records, and multi-omics—into a comprehensive knowledge graph. This sophisticated structure enables researchers to explore biological systems, develop testable hypotheses, discover new drug targets, and design potential drug candidates with greater assurance and lower chances of failure, thereby revolutionizing the field of medicine development. By pioneering such innovative strategies, BenevolentAI not only enhances the efficiency of pharmaceutical research but also significantly impacts the future of healthcare and treatment options. As a result, BenevolentAI is positioned as a leader in ushering in a transformative phase within the pharmaceutical sector.
Learn more
SciSpace BioMed Agent
SciSpace BioMed operates as a cutting-edge AI-driven "co-scientist" specifically designed for biomedical research, merging a vast collection of literature with an array of over 150 bio-tools and more than 100 academic databases and software applications to streamline complex research activities that span genomics, single-cell analysis, drug discovery, and clinical genomics. It enables researchers to interact using natural language, manage datasets, analyze genetic variants or multi-omics data, structure experimental workflows, reason through clinical biology and diseases, and create publication-ready outputs like figures, tables, and presentations while maintaining transparency and proper citation practices. Additionally, the platform features a “chat with PDF” option, allowing users to engage directly with scientific articles by highlighting text and seeking clarification on challenging material, thus serving as a valuable resource for understanding intricate methods and concepts. Moreover, for conducting literature reviews or initiating research, its AI-optimized semantic search can navigate millions of academic papers, yielding citation-supported summaries that foster a deeper comprehension of the relevant literature. This powerful functionality not only expedites the research journey but also empowers scientists to dedicate more time to their innovative discoveries rather than getting bogged down by administrative responsibilities, enhancing overall productivity in the field. Ultimately, SciSpace BioMed represents a significant advancement in how researchers approach complex biomedical inquiries, offering tools that make the research process both efficient and insightful.
Learn more
